Recent Finacing
Recent Raise
FAB Pharma is a Mutabilis spin-out discovering and developing low-molecular-weight antibacterials that inhibit the essential FabI fatty-acid biosynthesis enzyme to treat MRSA and bacterial infections, advancing toward clinical development.
Recent Investors
Total Raised
Funding round
Investors
